0001209191-19-006627.txt : 20190201
0001209191-19-006627.hdr.sgml : 20190201
20190201202412
ACCESSION NUMBER: 0001209191-19-006627
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190130
FILED AS OF DATE: 20190201
DATE AS OF CHANGE: 20190201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahatme Sandesh
CENTRAL INDEX KEY: 0001511034
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 19561413
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-30
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001511034
Mahatme Sandesh
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
EVP, CFO & CBO
Common Stock
2019-01-30
4
M
0
5469
13.71
A
14118
D
Common Stock
2019-01-30
4
M
0
1128
13.71
A
15246
D
Common Stock
2019-01-30
4
M
0
17860
13.90
A
33106
D
Common Stock
2019-01-30
4
M
0
19345
23.85
A
52451
D
Common Stock
2019-01-30
4
S
0
43802
130.00
D
8649
D
Common Stock
2019-01-31
4
M
0
21198
23.85
A
29847
D
Common Stock
2019-01-31
4
S
0
21198
130.72
D
8649
D
Common Stock
12012
I
By trust
Stock Option (right to buy)
13.71
2019-01-30
4
M
0
5469
0.00
D
2017-02-28
2026-02-28
Common Stock
5469
7404
D
Stock Option (right to buy)
13.71
2019-01-30
4
M
0
1128
0.00
D
2017-02-28
2026-02-28
Common Stock
1128
6771
D
Stock Option (right to buy)
13.90
2019-01-30
4
M
0
17860
0.00
D
2016-02-27
2025-02-27
Common Stock
17860
0
D
Stock Option (right to buy)
23.85
2019-01-30
4
M
0
19345
0.00
D
2013-11-05
2022-11-05
Common Stock
19345
96664
D
Stock Option (right to buy)
23.85
2019-01-31
4
M
0
21198
0.00
D
2013-11-05
2022-11-05
Common Stock
21198
75466
D
This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
/s/ David Tyronne Howton, as attorney-in-fact for Sandesh Mahatme
2019-02-01